NewLink Genetics Announces Review of Clinical Programs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
NewLink Genetics (NLNK) to Launch Review of Clinical Programs Following Announcement by Incyte and Merck
April 6, 2018 3:02 PM EDT(Updated - April 6, 2018 3:03 PM EDT)
NewLink Genetics Corporation (NASDAQ: NLNK) today announced a review of... More



